Cargando…

Exploiting Nucleotide Composition to Engineer Promoters

The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Grabherr, Manfred G., Pontiller, Jens, Mauceli, Evan, Ernst, Wolfgang, Baumann, Martina, Biagi, Tara, Swofford, Ross, Russell, Pamela, Zody, Michael C., Di Palma, Federica, Lindblad-Toh, Kerstin, Grabherr, Reingard M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097237/
https://www.ncbi.nlm.nih.gov/pubmed/21625601
http://dx.doi.org/10.1371/journal.pone.0020136
_version_ 1782203808093306880
author Grabherr, Manfred G.
Pontiller, Jens
Mauceli, Evan
Ernst, Wolfgang
Baumann, Martina
Biagi, Tara
Swofford, Ross
Russell, Pamela
Zody, Michael C.
Di Palma, Federica
Lindblad-Toh, Kerstin
Grabherr, Reingard M.
author_facet Grabherr, Manfred G.
Pontiller, Jens
Mauceli, Evan
Ernst, Wolfgang
Baumann, Martina
Biagi, Tara
Swofford, Ross
Russell, Pamela
Zody, Michael C.
Di Palma, Federica
Lindblad-Toh, Kerstin
Grabherr, Reingard M.
author_sort Grabherr, Manfred G.
collection PubMed
description The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of viral promoters. Here, we show how the nucleotide characteristics of highly active human promoters can be modelled via the genome-wide frequency distribution of short motifs: by overlapping motifs that occur infrequently in the genome, we constructed contiguous sequence that is rich in GC and CpGs, both features of known promoters, but lacking homology to real promoters. We show that snippets from this sequence, at 100 base pairs or longer, drive gene expression in vitro in a number of mammalian cells, and are thus candidates for use in protein production. We further show that expression is driven by the general transcription factors TFIIB and TFIID, both being ubiquitously present across cell types, which results in less tissue- and species-specific regulation compared to the viral promoter SV40. We lastly found that the strength of a promoter can be tuned up and down by modulating the counts of GC and CpGs in localized regions. These results constitute a “proof-of-concept” for custom-designing promoters that are suitable for biotechnological and medical applications.
format Text
id pubmed-3097237
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30972372011-05-27 Exploiting Nucleotide Composition to Engineer Promoters Grabherr, Manfred G. Pontiller, Jens Mauceli, Evan Ernst, Wolfgang Baumann, Martina Biagi, Tara Swofford, Ross Russell, Pamela Zody, Michael C. Di Palma, Federica Lindblad-Toh, Kerstin Grabherr, Reingard M. PLoS One Research Article The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of viral promoters. Here, we show how the nucleotide characteristics of highly active human promoters can be modelled via the genome-wide frequency distribution of short motifs: by overlapping motifs that occur infrequently in the genome, we constructed contiguous sequence that is rich in GC and CpGs, both features of known promoters, but lacking homology to real promoters. We show that snippets from this sequence, at 100 base pairs or longer, drive gene expression in vitro in a number of mammalian cells, and are thus candidates for use in protein production. We further show that expression is driven by the general transcription factors TFIIB and TFIID, both being ubiquitously present across cell types, which results in less tissue- and species-specific regulation compared to the viral promoter SV40. We lastly found that the strength of a promoter can be tuned up and down by modulating the counts of GC and CpGs in localized regions. These results constitute a “proof-of-concept” for custom-designing promoters that are suitable for biotechnological and medical applications. Public Library of Science 2011-05-18 /pmc/articles/PMC3097237/ /pubmed/21625601 http://dx.doi.org/10.1371/journal.pone.0020136 Text en Grabherr et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Grabherr, Manfred G.
Pontiller, Jens
Mauceli, Evan
Ernst, Wolfgang
Baumann, Martina
Biagi, Tara
Swofford, Ross
Russell, Pamela
Zody, Michael C.
Di Palma, Federica
Lindblad-Toh, Kerstin
Grabherr, Reingard M.
Exploiting Nucleotide Composition to Engineer Promoters
title Exploiting Nucleotide Composition to Engineer Promoters
title_full Exploiting Nucleotide Composition to Engineer Promoters
title_fullStr Exploiting Nucleotide Composition to Engineer Promoters
title_full_unstemmed Exploiting Nucleotide Composition to Engineer Promoters
title_short Exploiting Nucleotide Composition to Engineer Promoters
title_sort exploiting nucleotide composition to engineer promoters
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097237/
https://www.ncbi.nlm.nih.gov/pubmed/21625601
http://dx.doi.org/10.1371/journal.pone.0020136
work_keys_str_mv AT grabherrmanfredg exploitingnucleotidecompositiontoengineerpromoters
AT pontillerjens exploitingnucleotidecompositiontoengineerpromoters
AT maucelievan exploitingnucleotidecompositiontoengineerpromoters
AT ernstwolfgang exploitingnucleotidecompositiontoengineerpromoters
AT baumannmartina exploitingnucleotidecompositiontoengineerpromoters
AT biagitara exploitingnucleotidecompositiontoengineerpromoters
AT swoffordross exploitingnucleotidecompositiontoengineerpromoters
AT russellpamela exploitingnucleotidecompositiontoengineerpromoters
AT zodymichaelc exploitingnucleotidecompositiontoengineerpromoters
AT dipalmafederica exploitingnucleotidecompositiontoengineerpromoters
AT lindbladtohkerstin exploitingnucleotidecompositiontoengineerpromoters
AT grabherrreingardm exploitingnucleotidecompositiontoengineerpromoters